Invasive lobular carcinoma

From Wikipedia, the free encyclopedia

Invasive lobular carcinoma
Lobules of the mammary glands.
SpecialtyOncology
Histopathologic types of breast cancer, with relative incidences and prognoses, with "invasive lobular carcinoma" at top right

Invasive lobular carcinoma (ILC) is breast cancer arising from the lobules of the mammary glands.[1] It accounts for 5–10% of invasive breast cancer.[2][3] Rare cases of this carcinoma have been diagnosed in men (see male breast cancer).[4]

Most common features[5]
Classic lobular Pleomorphic lobular
GradesLow or high (II/III)High (III)
AJCC stageIII
Lymph node statusNegativePositive
ER/PR statusPositivePositive
Surgery typeLumpectomyMastectomy

The histologic patterns include:[6][7][8]

Type Prevalence Description Image
Classical 40% Round or ovoid cells with little cytoplasm in a single-file infiltrating pattern, sometimes concentrically giving a targetoid pattern
Mixed 40% No dominant pattern
Solid 10% Sheets of classical-appearing cells with little intervening stroma
Alveolar 5% Aggregates of classical-appearing cells
Tubulolobular 5% Cells form microtubules in >90% of tumor (smaller than in tubular carcinoma)
Pleomorphic Classical-appearing but with pleomorphic cells. It may include signet-ring cells, or plasmacytoid cells (pictured) which have abundant cytoplasm and eccentric nuclei.

Prognosis

Overall, the five-year survival rate of invasive lobular carcinoma was approximately 85% in 2003.[9]

Diagnosis

On mammography, ILC shows spiculated mass with ill-defined margins that has similar or lower density than surrounding breast tissues. This happens only at 44–65% of the time. Architectural distortion on surrounding breast tissues is only seen in 10–34% of the cases. It can be reported as benign in 8–16% of the mammography cases.[10]

Ultrasound has 68–98% sensitivity of detecting ILC. ILC shows irregular or angular mass with hypoechoic or heterogenous internal echoes, ill-defined or spiculated margins, and posterior acoustic shadowing.[10]

Loss of E-cadherin is common in lobular carcinoma but is also seen in other breast cancers.[11]

Treatment

References

Related Articles

Wikiwand AI